Drugs / EMICERFONT
Trials 10 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 16 trials | ||||||
| Phase 1 | NCT00508911 | Jun → Oct 2007 | social phobia | GlaxoSmithKline | Terminated | No outcome recorded |
| Phase 1 | NCT00555139 | Mar 2007 → Jan 2008 | social phobia | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT00424697 | Mar → Dec 2007 | — | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT00423761 | Dec 2006 → ? | — | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT00376896 | Nov 2006 → Oct 2008 | irritable bowel syndrome | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT00429728 | Nov 2006 → ? | — | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT00511563 | Aug 2007 → Nov 2012 | irritable bowel syndrome | GlaxoSmithKline | Withdrawn | No outcome recorded |
| Phase 2 | NCT00385099 | Dec 2006 → Oct 2007 | irritable bowel syndrome | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00397722 | Nov 2006 → Sep 2007 | social phobia | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00421707 | Oct 2006 → Jun 2008 | irritable bowel syndrome | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMICERFONT | ChEMBL registry synonym — accepted as the source's own label CHEMBL514270 ↗ |
| Known as | GW-876008X | ChEMBL registry synonym — accepted as the source's own label CHEMBL514270 ↗ |
| Known as | GW876008 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00385099 ↗ |
| Action | Inhibit | “Corticotrophin Releasing Factor 1 Receptor Antagonist (CRF1-RA)” NCT00376896 ↗1“Corticotropin releasing factor receptor 1 antagonist” CHEMBL514270 ↗ |
| Modality | Small molecule | — CHEMBL514270 ↗ |
| Route | Oral | “single oral dose of GW876008” NCT00429728 ↗ |
| Target | CRHR1 | “Corticotropin releasing factor receptor 1 antagonist” CHEMBL514270 ↗ |